Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody
- PMID: 1433404
Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody
Abstract
A successful experimental treatment for gram-positive sepsis to our knowledge has not been achieved. The objectives of this study were to develop a nonhuman primate model of lethal gram-positive sepsis employing the micro-organism Staphylococcus aureus and to determine the efficacy of treatment using monoclonal antibody (MAb) to tumor necrosis factor alpha (TNF). The antibody was administered intravenously, 15 mg/kg, 30 minutes after the beginning of a 2-hour infusion of S. aureus, 4 x 10(10) colony forming units/kilogram. The baboons infused with S. aureus demonstrated the release of the cytokines TNF and interleukin-6 (IL-6), but endotoxin was not observed in the plasma at any time. Treatment with antibody to TNF abolished the rise in serum TNF levels and reduced the increased levels of IL-6. Treatment with MAb to TNF prevented multiple organ failure and achieved permanent (> 7 day) survival of all baboons.
Similar articles
-
Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha).Circ Shock. 1990 Mar;30(3):279-92. Circ Shock. 1990. PMID: 2178801
-
Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model.Circ Shock. 1992 Oct;38(2):75-84. Circ Shock. 1992. PMID: 1423924
-
Monoclonal antibody to tumor necrosis factor--alpha prevents lethal endotoxin sepsis in adult rhesus monkeys.J Lab Clin Med. 1992 Oct;120(4):574-88. J Lab Clin Med. 1992. PMID: 1402333
-
Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.Prog Clin Biol Res. 1991;367:141-59. Prog Clin Biol Res. 1991. PMID: 1924424 Review.
-
Therapy with antibody to tumor necrosis factor in sepsis.Clin Infect Dis. 1993 Nov;17 Suppl 2:S515-9. doi: 10.1093/clinids/17.supplement_2.s515. Clin Infect Dis. 1993. PMID: 8274618 Review.
Cited by
-
Involvement of NO in the failure of neutrophil migration in sepsis induced by Staphylococcus aureus.Br J Pharmacol. 2002 Jul;136(5):645-58. doi: 10.1038/sj.bjp.0704734. Br J Pharmacol. 2002. PMID: 12086974 Free PMC article.
-
Increasing the efficacy of anti-inflammatory agents used in the treatment of sepsis.Eur J Clin Microbiol Infect Dis. 2003 Jan;22(1):1-9. doi: 10.1007/s10096-002-0857-3. Epub 2003 Jan 28. Eur J Clin Microbiol Infect Dis. 2003. PMID: 12582737 Review.
-
Induction of nitric oxide production by polyosides from the cell walls of Streptococcus mutans OMZ 175, a gram-positive bacterium, in the rat aorta.Infect Immun. 1997 Jun;65(6):2074-9. doi: 10.1128/iai.65.6.2074-2079.1997. Infect Immun. 1997. PMID: 9169734 Free PMC article.
-
Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer.Br J Pharmacol. 1996 Jun;118(3):649-58. doi: 10.1111/j.1476-5381.1996.tb15450.x. Br J Pharmacol. 1996. PMID: 8762090 Free PMC article.
-
The protective and immunomodulatory effects of hypothalamic proline-rich polypeptide galarmin against methicillin-resistant Staphylococcus aureus infection in mice.Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2153-65. doi: 10.1007/s10096-012-1550-9. Epub 2012 Feb 11. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22322358
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical